NDC properties for NDC 9 0065-0741
NDC item 00065074114
| NDC 9 | 0065-0741 |
|---|---|
| NDC 10 | 0065-0741-14 |
| NDC Item | 00065074114 |
| packaging | 12 BLISTER PACK in 1 CARTON (0065-0741-14) / 1 BOTTLE, DROPPER in 1 BLISTER PACK / 4 mL in 1 BOTTLE, DROPPER |
| Labeler | Alcon Laboratories, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2016-11-02 |
| Marketing status | ACTIVE |
| NDA | NDA208135 |
NDC item 00187092005
| NDC 9 | 0187-0920 |
|---|---|
| NDC 10 | 0187-0920-05 |
| NDC Item | 00187092005 |
| packaging | 1 BOTTLE in 1 CARTON (0187-0920-05) / 5 mL in 1 BOTTLE |
| Labeler | Bausch Health US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2027-04-30 |
| Marketing effective time low | 2019-06-27 |
| Marketing status | ACTIVE |
| NDA | NDA210821 |
NDC item 24208009205
| NDC 9 | 24208-092 |
|---|---|
| NDC 10 | 24208-092-05 |
| NDC Item | 24208009205 |
| packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-092-05) / 5 mL in 1 BOTTLE, DROPPER |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2022-09-23 |
| Marketing status | ACTIVE |
| NDA | NDA210821 |
NDC item 24208009215
| NDC 9 | 24208-092 |
|---|---|
| NDC 10 | 24208-092-15 |
| NDC Item | 24208009215 |
| packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-092-15) / 15 mL in 1 BOTTLE, DROPPER |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2022-09-23 |
| Marketing status | ACTIVE |
| NDA | NDA210821 |
NDC item 49999026815
| NDC 9 | 49999-268 |
|---|---|
| NDC 10 | 49999-268-15 |
| NDC Item | 49999026815 |
| packaging | 1 BOTTLE, DROPPER in 1 CARTON (49999-268-15) / 15 mL in 1 BOTTLE, DROPPER |
| Labeler | Lake Erie Medical DBA: Quality Care Products LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time high | 2019-10-11 |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| UNAPPROVED_DRUG_OTHER | N/A |
NDC item 50090236401
| NDC 9 | 50090-2364 |
|---|---|
| NDC 10 | 50090-2364-1 |
| NDC Item | 50090236401 |
| packaging | 4 mL in 1 BOTTLE, DROPPER (50090-2364-1) |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2016-11-02 |
| Marketing status | ACTIVE |
| NDA | NDA208135 |
NDC item 51394021415
| NDC 9 | 51394-214 |
|---|---|
| NDC 10 | 51394-214-15 |
| NDC Item | 51394021415 |
NDC item 66267092415
| NDC 9 | 66267-924 |
|---|---|
| NDC 10 | 66267-924-15 |
| NDC Item | 66267092415 |
| packaging | 15 mL in 1 BOX (66267-924-15) |
| Labeler | NuCare Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time high | 2018-12-31 |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| UNAPPROVED_DRUG_OTHER | N/A |
NDC item 68682092005
| NDC 9 | 68682-920 |
|---|---|
| NDC 10 | 68682-920-05 |
| NDC Item | 68682092005 |
| packaging | 1 BOTTLE in 1 CARTON (68682-920-05) / 5 mL in 1 BOTTLE |
| Labeler | Oceanside Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2027-04-30 |
| Marketing effective time low | 2019-06-27 |
| Marketing status | ACTIVE |
| NDA | NDA210821 |
NDC item 68682092064
| NDC 9 | 68682-920 |
|---|---|
| NDC 10 | 68682-920-64 |
| NDC Item | 68682092064 |
| packaging | 1 BOTTLE in 1 CARTON (68682-920-64) / 15 mL in 1 BOTTLE |
| Labeler | Oceanside Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2027-04-30 |
| Marketing effective time low | 2019-06-27 |
| Marketing status | ACTIVE |
| NDA | NDA210821 |
NDC item 70069059601
| NDC 9 | 70069-596 |
|---|---|
| NDC 10 | 70069-596-01 |
| NDC Item | 70069059601 |
| packaging | 1 BOTTLE in 1 CARTON (70069-596-01) / 5 mL in 1 BOTTLE |
| ANDA | ANDA217227 |
| Labeler | Somerset Therapeutics, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-12-23 |
| Marketing status | ACTIVE |
NDC item 70069059701
| NDC 9 | 70069-597 |
|---|---|
| NDC 10 | 70069-597-01 |
| NDC Item | 70069059701 |
| packaging | 1 BOTTLE in 1 CARTON (70069-597-01) / 15 mL in 1 BOTTLE |
| ANDA | ANDA217227 |
| Labeler | Somerset Therapeutics, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-12-23 |
| Marketing status | ACTIVE |
NDC item 70518418300
| NDC 9 | 70518-4183 |
|---|---|
| NDC 10 | 70518-4183-0 |
| NDC Item | 70518418300 |
| packaging | 12 BOTTLE, DROPPER in 1 CARTON (70518-4183-0) / 4 mL in 1 BOTTLE, DROPPER (70518-4183-1) |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-09-24 |
| Marketing status | ACTIVE |
| NDA | NDA208135 |
NDC item 70518418301
| NDC 9 | 70518-4183 |
|---|---|
| NDC 10 | 70518-4183-1 |
| NDC Item | 70518418301 |
| packaging | 4 mL in 1 BOTTLE, DROPPER |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-09-24 |
| Marketing status | ACTIVE |
| NDA | NDA208135 |
NDC item 82260092005
| NDC 9 | 82260-920 |
|---|---|
| NDC 10 | 82260-920-05 |
| NDC Item | 82260092005 |
| packaging | 1 BOTTLE, DROPPER in 1 CARTON (82260-920-05) / 5 mL in 1 BOTTLE, DROPPER |
| Labeler | Bausch & Lomb Americas Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2022-09-21 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA210821 |
NDC item 82260092015
| NDC 9 | 82260-920 |
|---|---|
| NDC 10 | 82260-920-15 |
| NDC Item | 82260092015 |
| packaging | 1 BOTTLE, DROPPER in 1 CARTON (82260-920-15) / 15 mL in 1 BOTTLE, DROPPER |
| Labeler | Bausch & Lomb Americas Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2022-09-21 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA210821 |